Literature DB >> 6572921

Human coagulation factor Va is a cofactor for the activation of protein C.

H H Salem, G J Broze, J P Miletich, P W Majerus.   

Abstract

During blood clotting in vitro, protein C is converted in part to protein Ca, Protein Ca, in turn, inactivates factor Va. This is evidenced by the rapid inactivation of factor Va coagulant activity after clot formation which is associated with the cleavage of the Mr 110,000 peptide of factor Va. When exogenous factor Va is added to serum, it is inactivated only after a lag of 10-20 min. Using purified coagulation factors in the presence of EDTA, we demonstrated that factor Va enhances the rate of protein C activation by thrombin by 50-fold. The Km for factor Va in the reaction is 14 nM, 100 times higher than its Km for accelerating platelet surface prothrombin activation by factor Xa. By this mechanism, factor Va can act as a procoagulant as well as limit dissemination of the coagulation process through the activation of protein C and the subsequent inactivation of both factor Va and factor VIIIa.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6572921      PMCID: PMC393646          DOI: 10.1073/pnas.80.6.1584

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  22 in total

1.  A new vitamin K-dependent protein. Purification from bovine plasma and preliminary characterization.

Authors:  J Stenflo
Journal:  J Biol Chem       Date:  1976-01-25       Impact factor: 5.157

2.  A new vitamin K-dependent protein. A phospholipid-binding zymogen of a serine esterase.

Authors:  C T Esmon; J Stenflo; J W Suttie
Journal:  J Biol Chem       Date:  1976-05-25       Impact factor: 5.157

3.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

4.  The inhibition of blood coagulation by activated Protein C through the selective inactivation of activated Factor V.

Authors:  F J Walker; P W Sexton; C T Esmon
Journal:  Biochim Biophys Acta       Date:  1979-12-07

5.  Deficiency of factor Xa-factor Va binding sites on the platelets of a patient with a bleeding disorder.

Authors:  J P Miletich; W H Kane; S L Hofmann; N Stanford; P W Majerus
Journal:  Blood       Date:  1979-11       Impact factor: 22.113

6.  Hemorrhagic death associated with a high titer factor V inhibitor.

Authors:  M C Coots; A F Muhleman; H I Glueck
Journal:  Am J Hematol       Date:  1978       Impact factor: 10.047

7.  Interaction of coagulation factor Xa with human platelets.

Authors:  J P Miletich; C M Jackson; P W Majerus
Journal:  Proc Natl Acad Sci U S A       Date:  1977-09       Impact factor: 11.205

8.  Proteolytic activation of protein C from bovine plasma.

Authors:  W Kisiel; L H Ericsson; E W Davie
Journal:  Biochemistry       Date:  1976-11-02       Impact factor: 3.162

9.  Patients with congenital factor V deficiency have decreased factor Xa binding sites on their platelets.

Authors:  J P Miletich; D W Majerus; P W Majerus
Journal:  J Clin Invest       Date:  1978-10       Impact factor: 14.808

10.  Human plasma protein C: isolation, characterization, and mechanism of activation by alpha-thrombin.

Authors:  W Kisiel
Journal:  J Clin Invest       Date:  1979-09       Impact factor: 14.808

View more
  8 in total

1.  Cloning of a cDNA coding for human factor V, a blood coagulation factor homologous to factor VIII and ceruloplasmin.

Authors:  W H Kane; E W Davie
Journal:  Proc Natl Acad Sci U S A       Date:  1986-09       Impact factor: 11.205

2.  Inhibition of activated protein C by platelets.

Authors:  S M Jane; C A Mitchell; L Hau; H H Salem
Journal:  J Clin Invest       Date:  1989-01       Impact factor: 14.808

3.  Effects of thrombomodulin and coagulation Factor Va-light chain on protein C activation in vitro.

Authors:  H H Salem; N L Esmon; C T Esmon; P W Majerus
Journal:  J Clin Invest       Date:  1984-04       Impact factor: 14.808

4.  Specificity of activated human protein C.

Authors:  S R Stone; J Hofsteenge
Journal:  Biochem J       Date:  1985-09-01       Impact factor: 3.857

5.  Coagulation factor Va binds to human umbilical vein endothelial cells and accelerates protein C activation.

Authors:  I Maruyama; H H Salem; P W Majerus
Journal:  J Clin Invest       Date:  1984-07       Impact factor: 14.808

6.  Detection of protein C activation in humans.

Authors:  K A Bauer; B L Kass; D L Beeler; R D Rosenberg
Journal:  J Clin Invest       Date:  1984-12       Impact factor: 14.808

7.  Inactivation of human factor VIII by activated protein C. Cofactor activity of protein S and protective effect of von Willebrand factor.

Authors:  J A Koedam; J C Meijers; J J Sixma; B N Bouma
Journal:  J Clin Invest       Date:  1988-10       Impact factor: 14.808

8.  Biosynthesis of coagulation Factor V by a human hepatocellular carcinoma cell line.

Authors:  D B Wilson; H H Salem; J S Mruk; I Maruyama; P W Majerus
Journal:  J Clin Invest       Date:  1984-03       Impact factor: 14.808

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.